Connect with:
Sunday / December 22. 2024
HomePosts Tagged "gene editing"

Biographica’s proprietary AI platform linked with Cibus’ crop editing abilities provide opportunities for discovery and commercial application.

Cibus, Inc., a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, and Biographica, a UK-based leader in AI and graph machine learning for gene discovery, are pleased to announce a collaborative pilot project focused on advancing disease resistance in oilseed rape and Canola.

This partnership leverages Biographica’s proprietary platform to identify and prioritise targets for gene editing, aiming to develop resistance against critical diseases impacting crop health, yield and quality. Under this agreement, Biographica will utilise its cutting-edge AI and machine learning technology to analyse gene targets associated with disease resistance in oilseed rape and Canola and set the stage for future crop improvement strategies.

“This collaboration marks a significant milestone in unlocking the potential of advanced machine learning for agricultural innovation,” said Cecy Price, CEO at Biographica. “Combining Biographica’s unique machine learning trait discovery platform with Cibus’ expertise in crop trait development allows us to unlock new insights into disease resistance, paving the way for more resilient crops and sustainable agricultural practices.”

Tony Moran, Senior Vice President for International Development at Cibus, added, “We are excited to work alongside Biographica to identify impactful gene targets, enabling the development of crop varieties that can withstand disease pressure in the field with benefits for farmers, the environment, and food security.”

Dr. Greg Gocal, Executive Vice President and Chief Scientific Officer, added, “We have made plant disease resistance an important pillar of our work. This is a critically important need in farming. Developing durable disease resistance in plants will require identifying multiple modes of action. This partnership with Biographica is an important extension of our work in building our inventory of gene targets associated with developing different modes of action for this important trait.”

The collaboration reflects a commitment by both companies to push the boundaries of crop science and contribute to sustainable agriculture. This pilot project has the potential to accelerate the delivery of improved crop varieties with advanced disease resistant traits to farmers worldwide.

Biographica’s proprietary AI platform linked with Cibus’

The Company plans to fully integrate this trait into its elite commercial corn line by the end of 2024.

Origin Agritech Ltd., a leading Chinese agricultural technology company, announced a major breakthrough in corn production technology. Building on the Company’s track record of innovation, Origin Agritech has developed a high-yield corn inbred line that significantly surpasses the productivity of traditional corn. This groundbreaking advancement was achieved through precise gene editing techniques, marking a significant milestone in the company’s commitment to sustainable and efficient agriculture.

Over the course of two years of rigorous multilocational field trials, the new gene-edited corn inbred line demonstrated a yield increase of over 50% compared to the original line. This leap in productivity has the potential to addressing global food security challenges through cutting-edge agricultural technologies.

Dr Gengchen Han, Chairman and CEO of Origin Agritech, stated, “The significant increase in yield potential heralds a new era in corn production, offering a sustainable solution to meet the growing global demand for food. We believe that our gene-edited high-yield corn will play a crucial role in enhancing food security and sustainability worldwide.”

The Company plans to fully integrate this trait into its elite commercial corn line by the end of 2024. This integration is expected to greatly enhance seed yield and significantly reduce the cost of hybrid seed production. In addition, Origin will conduct field demonstrations and seed production trials in the summer of 2024. These events will showcase the technology’s performance and its potential impact on the agriculture industry.

The Company plans to fully integrate this

It is building a platform that leverages gene editing techniques to fix the innate immune system of crops

Resurrect Bio, a biotechnology startup announce the completion of a seed investment round which totals £1.61million. The investment was led by SynBioVen and also included UKI2S, AgFunder and SHAKE Climate Change Accelerator.

Resurrect Bio is a spin-out company of The Sainsbury Laboratory in Norwich.  It is building a platform that leverages gene editing techniques to fix the innate immune system of crops and make crops more resistant to disease, which is critical if we want to reduce the use of agrichemicals while feeding an increasing world population.

Resurrect Bio uses the latest scientific discoveries, combining a unique blend of computational biology, Artificial Intelligence (AI), and synthetic biology methods to rapidly identify and resurrect native disease-resistance genes in crops. With this new investment, Resurrect Bio will accelerate product development and strengthen its underlying disease-resistance trait-discovery platform.

The company partners with key members of the seed industry to enable the rapid delivery of gene-edited disease-resistant seeds so that farmers will be provided with the option to enhance their crop yield and reduce dependence on agrichemicals.

Recently the Precision Breeding Act received royal assent and it is anticipated that gene-edited crops will become much more accessible in England.

“Resurrect Bio is thrilled to have secured this investment from such a strong group of partners who share our vision of delivering disease-resistant crops to farmers,” said Dr Cian Duggan, CEO of Resurrect Bio. “This funding will enable us to accelerate our mission and make significant strides towards more sustainable agriculture.”

“Oliver Sexton, Investment Director UKI2S commented, ‘The fund backs world-changing technology at an early stage and Resurrect Bio is a great example of that ambition. Its platform will lead to reduced pesticide use and UKI2S is delighted to help Cian and the team build their technology.”

It is building a platform that leverages

 By Dr Ratna Kumria, Director, Biotechnology Alliance for Agri Innovation (AAI)

Gene editing offers an accurate, predictable, quick, and economical method for crop improvement. Due to its precision, it offers the opportunity to increase nutrient levels, decrease anti-nutrients, and improve the shelf life of food to preserve quality and nutrition. This technology cannot provide solutions for all farming challenges or plant breeding bottlenecks, but it can certainly streamline the process towards greater efficiency. It provides an opportunity to address hunger and malnutrition regionally using traditional, local crops. It can also enable local solutions to conserve biodiversity and resources, moving towards better agriculture.

Gene editing refers to making changes in the genome of an organism using various nucleases with distinct specificities and modes of action. The nucleases are programmed to target particular sequences for cutting, although the repair mechanisms can either be random or designed with external templates. While traditional nucleases cut both strands of DNA, some have been adapted to cut a single strand and utilise RNA as a template for making alterations. The selection of the appropriate gene editing tool is based on the target’s cost and feasibility. As new nucleases are being discovered and editing tools developed, gene editing is finding diverse applications. Although currently used in therapeutics, it is expected to have far-reaching effects on crop improvement and agriculture.

Humans have been selectively breeding plants and animals for centuries, long before the field of genetics was established. Today’s cultivated crops, whether ornamental or used for food, as well as domesticated animals are very different from their wild counterparts. For example, maize was selected and bred from its ancestor teosinte and likewise the fibrous, blander version of ancient watermelon fruits, as also other food crops were bred for a better flavour and texture that is more palatable to humans. Domesticating plants and animals are a painstaking and repetitive process that has been ongoing for hundreds, and sometimes thousands, of years.

Advancements in genetics have accelerated plant breeding and crop improvement over the past century. With the knowledge of genetics, breeders were able to identify variations and select for new genetic combinations that were better suited for cultivation and consumption. In addition to identifying variations, breeders have also been using chemicals or radiation to induce random mutations that result in beneficial genetic modifications. This mutation breeding has led to the creation of over 3000 new varieties of crops across the globe, during the last few decades. As a result of these plant breeding efforts, cereal crop production has tripled during this period, with only a 30 per cent increase in land under cultivation. India’s green revolution, which transformed it from a food-deficient nation to a food-surplus one, owes much of its success to plant breeding efforts.

However, the haphazard nature of mutation-generation makes selecting the relevant modifications an expensive, time-consuming, and laborious process. Conventional breeding is a lengthy process that depends on the number and duration of growing seasons per year, as well as the time it takes for plants to mature. This process can be even more prolonged when dealing with trees, perennials or assembling multiple traits through multi-stage crossing, selection, and testing. Additionally, the randomness of induced mutagenesis adds another dimension to the selection and testing required for large-scale screening. To make the breeding process more efficient over time, various technological interventions have been introduced, including molecular markers, double haploids, genome-wide association studies (GWAS), and other prediction tools.

To read more click on: https://agrospectrumindia.com/e-magazine

 By Dr Ratna Kumria, Director, Biotechnology Alliance

This platform functions efficiently at temperatures as low as 4°C.

The CRISPR gene-editing technology has scaled to a new height in India. Indian scientists have demonstrated for the first time that the associated Cas9 enzyme, which acts as molecular scissors to cut DNA at a location specified by a guide RNA, can bind to and cut the target DNA at very low temperatures.

This work has shown the highly efficient functioning of this platform at temperatures as low as 4°C. making it possible to edit genes in temperature sensitive organisms, plants, or crop varieties.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are short DNA sequences found in the genome of prokaryotic organisms such as bacteria, which are reminders of previous bacteriophage (viruses) attacks that the bacteria successfully defended against. Cas9 enzyme (part of bacteria’s defence mechanism) uses these flags to precisely target and cut any foreign DNA, thus protecting the bacteria from future attacks by similar bacteriophages. The unprecedented precision of targeting the DNA sequences and then efficiently cutting them is the basis for CRISPR-Cas9 technology, which has been recently demonstrated in editing genes in cells and organisms.

CRISPR-Cas9 technology has been successfully used for many purposes, including basic studies of gene function, agriculture, and medicine to increase our knowledge of disease processes and their potential future therapies. So far, most binding trials were typically performed at 37 °C.

As a further step to advance this platform into the forefront of biomedical and analytical biotechnology, scientists of Raman Research Institute (RRI), an autonomous institute of the Department of Science and Technology (DST), have explored temperature-dependent binding and release of cleaved products by the Cas9 enzyme. Serene Rose David, Sumanth Kumar Maheshwaram, Divya Shet & Mahesh B. Lakshminarayana, under the guidance of Dr Gautam V Soni, have demonstrated that the Cas9 enzymes strongly bind to the target at very low temperatures and remains bound to the cleaved DNA products even after the enzyme has done its job.

Subsequently, the bound products were released in a controlled fashion using high temperature or chemical denaturant (that make proteins and DNA lose their 3-dimensional structure and become non-functional). The research published in the Scientific Reports journal of the Nature Portfolio expands possible application of the Cas9-based genetic toolbox to a previously unexplored temperature range that would be compatible with long-term storage of biological samples.

This platform functions efficiently at temperatures as

Discussions will be held on sustainable agriculture, better nutrition, health benefits, and environmental sustainability

Glostem will organise national workshop cum webinar on genome editing from June 27 to July 3, 2022. The conference will be chaired by Prof KC Bansal, Secretary, NAAS, India and Co-chaired by PROF Yiping Qi, Univ. Maryland, USA.

The seven-day online workshop will cover the basics of genome editing as investigated by researchers in different organisms including model plant species, Drosophila melanogaster,
Caenorhabditis elegans, yeast, mammalian and stem cells, and elaborate on its application for sustainable agriculture, better nutrition, health benefits, and environmental sustainability. Future developments and directions of the emerging genome editing tools and technologies will also be discussed.

The faculty for the workshop is drawn from reputed national institutes like IISc, Bangalore; NCBS, Bangalore; CSIR-IGIB, New Delhi; CSIR-CCMB, Hyderabad; IIT, Kharagpur; DBT-NABI, Mohali; DBT-NIPGR, New Delhi; IISER, Mohali; ICAR-IARI, New Delhi and ICAR-NRRI, Cuttack.

Scientists and researchers from academics and industry working in the field of plant, human, and animal biotechnology including agricultural biotechnology, plant genetics and genomics, plant breeding, crop improvement, disease resistance, stress tolerance, plant-microbe interaction, functional genomics, transcriptomics, metabolomics, molecular biology, pharmacogenomics, personalised medicine and synthetic biology.

Experts will elaborate on the application of Genome Editing for sustainable agriculture, better nutrition, health benefits and environmental sustainability.

Discussions will be held on sustainable agriculture,